Accelerate Diagnostics, Inc. (LON:0H8E)
London · Delayed Price · Currency is GBP · Price in USD 0.0126
+0.0001 (0.80%)
At close: May 22, 2025
Accelerate Diagnostics Market Cap
Accelerate Diagnostics has a market cap or net worth of 18.87 as of August 1, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
18.87
Enterprise Value
37.96M
Revenue
9.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since December 15, 1995, Accelerate Diagnostics's market cap has decreased from 1.86M to 18.87, a decrease of -100.00%. That is a compound annual growth rate of -32.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 18.87 | -100.00% |
| Dec 31, 2024 | 24.01M | -46.39% |
| Dec 29, 2023 | 44.78M | -22.88% |
| Dec 30, 2022 | 58.07M | -78.38% |
| Dec 31, 2021 | 268.56M | -15.18% |
| Dec 31, 2020 | 316.62M | -54.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.19B |
| GSK plc | 56.39B |
| Haleon | 32.84B |
| Smith & Nephew | 10.12B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.27B |
| HUTCHMED (China) | 2.26B |
| Oxford Nanopore Technologies | 1.92B |